Download Library

 
 
 
Download Library
Document Type
Daratumumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (MMY1001) - ASH abstract - November 2017 (Chari)
URL
N/A
Daratumumab in Combination with Lenalidomide Plus Dexamethasone Results in Persistent Natural Killer Cells with a Distinct Phenotype and Expansion of Effector Memory T-cells in POLLUX - ASH abstract - November 2017 (van de Donk)
URL
N/A
Daratumumab, Bortezomib and Dexamethasone vs Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Efficacy and Safety Analysis of CASTOR - ASH abstract - November 2017 (Spencer)
URL
N/A
Cost-effectiveness of Daratumumab Plus Bortezomib and Dexamethasone Versus Bortezomib Plus Dexamethasone for Treatment of Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy: an Analysis of the CASTOR Trial - ASH abstract - November 2017 (Maiese)
URL
N/A
Cost-effectiveness of Daratumumab Plus Lenalidomide Plus Dexamethasone vs Lenalidomide Plus Dexamethasone for Treatment of Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy: an Analysis of the POLLUX Trial - ASH abstract - November 2017 (Maiese)
URL
N/A
Efficacy and Safety of Ofatumumab and Bendamustine Followed by Ofatumumab Maintenance in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma After Prior Rituximab - ASH abstract - November 2017 (Kolibaba)
URL
N/A
Investor Presentation, September 2017
PDF
2.6 MB
A Phase I/II Safety Study of Tisotumab Vedotin (HuMax-TF-ADC) in Patients With Solid Tumours - ESMO Poster - September 2017 (Chenard-Poirier)
PDF
958.9 KB
A Phase IIA Study of Tisotumab Vedotin (HuMax-TF-ADC) in Patients with Relapsed, Recurrent and / or Metastatic Cervical Cancer - ESMO presentation - September 2017 (Vergote)
PDF
626.4 KB
A phase I/II safety study of tisotumab vedotin (HuMax-TF-ADC) in patients with solid tumors - ESMO abstract - August 2017 (Chenard-Poirier)
URL
N/A
A phase IIa study of tisotumab vedotin (HuMax-TF-ADC) in patients with relapsed, recurrent and/or metastatic cervical cancer - ESMO abstract - August 2017 (Vergote)
URL
N/A
Interim Report for the First Half 2017
pdf
571.2 KB
Genmab First Half 2017 Results Presentation
PDF
157.1 KB
Q2 2017 Results Podcast
MP3
24.9 MB
10th Kempen & Co. Life Science Conference - April 2017
PDF
1.5 MB
Development of a clinical trial immunohistochemistry assay using a novel antibody to CD38 - ASCO presentation - June 2017 (Wakamiya)
PDF
896.7 KB
First-in-human trial to evaluate safety of HuMax-Axl-ADC in patients with solid tumors - ASCO poster - June 2017 (Lassen)
PDF
2.7 MB
Daratumumab in combination with KRd in patients with newly diagnosed multiple myeloma (MMY1001) - ASCO presentation - June 2017 (Jakubowiak)
PDF
787.3 KB
Efficacy of DRd or DVd in RRMM based on cytogenetic risk status - ASCO presentation - June 2017 (Weisel)
PDF
754.8 KB
Phase Ib/II atezolizumab with or without daratumumab in previously treated advanced or metastatic NSCLC - ASCO abstract - May 2017 (Pillai)
PDF
81.7 KB
Daratumumab in combination with KRd in patients with newly diagnosed multiple myeloma (MMY1001) - ASCO presentation - June 2017 (Jakubowiak)
PDF
83.7 KB
Efficacy of DRd or DVd in RRMM based on cytogenetic risk status - ASCO abstract - May 2017 (Weisel)
PDF
97.0 KB
DRd vs Rd in RRMM: Efficacy and safety update (POLLUX) -ASCO abstract - May 2017 (Bahlis)
PDF
89.7 KB
Safety and efficacy of daratumumab-based regimens in elderly patients with RRMM: Subgroup analysis of POLLUX and CASTOR - ASCO abstract - May 2017 (Mateos)
PDF
150.8 KB
DVd vs Vd in RRMM: Efficacy and safety update (CASTOR) - ASCO abstract - May 2017 (Lentzsch)
PDF
87.3 KB

Page: First Previous
1
2
3
4
5
6
7
...
19
Next Last

 
 
 

Please be advised that additional documents and media, such as fact sheets and conference call webcasts, are available only in English and can be accessed by clicking on the English tab.

 

Download Library
Document Type
Kvartalsrapport for 1. kvartal 2008
PDF
263.1 KB
Årsrapport 2007
PDF
2.2 MB
Kvartalsrapport for perioden 1. januar til 30. september 2007
PDF
284.5 KB
Halvårsrapport pr. 30. juni 2007
PDF
274.6 KB
Kvartalsrapport for kvartal 2007
PDF
116.0 KB
Årsrapport 2006
PDF
2.2 MB
Årsregnskabsmeddelelse 2006
PDF
411.9 KB
Halvårsrapport pr. 30. juni 2006
PDF
119.3 KB
Kvartalsrapport for 1.kvartal 2006
PDF
203.6 KB
Årsrapport 2005
PDF
1.0 MB
Årsregnskabsmeddelelse 2005
PDF
514.5 KB
Kvartalsrapport 3. kvartal 2005
PDF
217.0 KB
Halvårsrapport første halvår 2005
PDF
205.4 KB
Kvartalsrapport for 1. kvartal 2005
PDF
197.7 KB
Årsrapport 2004
PDF
1.3 MB
Kvartalsrapport 3. kvartal 2004
PDF
214.7 KB
Halvårsrapport første halvår 2004
PDF
211.2 KB
Kvartalsrapport 1.kvartal 2004
PDF
184.9 KB
Årsrapport 2003
PDF
921.8 KB
Kvartalsrapport 3. kvartal 2003
PDF
194.4 KB
Halvårsrapport Første halvår 2003
PDF
190.9 KB
Kvartalsrapport 1.kvartal 2003
PDF
173.7 KB
Årsrapport 2002
PDF
1.5 MB
Kvartalsrapport 3.kvartal 2002
PDF
176.9 KB
Halvårsrapport Første halvår 2002
PDF
66.2 KB
Page: First Previous
1
2
3
4
Next Last